Agilent Technologies Inc - Company Profile
Powered by 
All the data and insights you need on Agilent Technologies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Agilent Technologies Inc Strategy Report
- Understand Agilent Technologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Business Description
Agilent Technologies Inc (Agilent) provides application focused solutions including instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its offerings also serve customers in clinical and life sciences research areas, allowing them to cross-examine samples at the molecular level. Its major products include liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; atomic absorption instruments; hematoxylin & eosin; inductively coupled plasma mass spectrometry instruments; lab supplies for chromatography & spectroscopy; dissolution testing; vacuum pumps and measurement technologies. The company operates through three business segments, namely Life Sciences and Applied Markets, Agilent CrossLab, and Diagnostics and Genomics.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Agilent Technologies focuses on significant research and development projects to maintain its competitive position with a continuous flow of innovative, high-quality products and services. The company's R&D efforts emphasize on potential new products and product improvements covering a wide variety of technologies. The research seeks to improve on various technical competencies in software, systems and solutions, life sciences, and diagnostics. The company has R&D facilities in several countries including Australia, China, Germany, Italy, Japan, Malaysia, Netherlands, Singapore, the United Kingdom, the US, Belgium, and Denmark. In FY2023, it reported R&D expenses of US$481 million, which accounted for 7% of the total revenue.
Business Segments
Overview
Business covers the entire lab with consumable and service portfolio, which would enhance customer outcomes. Solutions range from supplies and chemistries to services and software helping to connect the entire lab. It serves pharmaceutical, biotechnology, CRO and CMO; academic and government; chemical and energy; environmental and forensic; diagnostic and clinical; and food markets. - Major products in consumables include GC and LC columns, custom chemistries, filtration products, sample preparation products, instrument replacement parts, scientific instrument parts and supplies, and a range of laboratory instrument supplies. - Major services include startup, operational, training and compliance support; integrated laboratory management services such as instrument services, asset management, procurement, lab supply management, informatics and scientific services. Views product innovation as a critical factor for the growth of the segment.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Comprises the genomics, pathology, nucleic acid contract manufacturing and research and development, companion diagnostics, biomolecular analysis and reagent partnership businesses. It includes six areas of activity providing APIs for oligo-based therapeutics and solutions that comprise reagents, software, consumables and instruments, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The segment serves the diagnostics and clinical market. - Major offerings include pathology products, specific proteins and flow reagents, target enrichment, cytogenetic research solutions and microarrays, PCR and qPCR instrumentation, automated electrophoresis, companion diagnostics, microfluidics, molecular biology reagents and nucleic acid solutions. Considers investing, expanding and improving its applications and solutions portfolio in the diagnostic markets and enhancing its position in developing and emerging markets as major factors for growth.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
Provides application focused solutions including instruments and software that enable customers to identify, quantify and analyze the biological and physical properties of substances and products. Its offerings also help customers in clinical and life sciences research areas, allowing them to cross-examine samples at the molecular and cell level. It focuses on the pharmaceutical, biotechnology, CRO and CMO; chemical and energy; academic and government; environmental and forensics; and food markets. Major products include liquid and gas chromatography systems and components; liquid and gas chromatography mass spectrometry systems; atomic absorption instruments; inductively coupled plasma mass spectrometry instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps and measurement technologies. Views product innovation and acquisitions as critical contributors to growth.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward